During a live event, Ahmad Tarhini, MD, PhD, moderated a discussion on selection of immunotherapy regimens for patients with ...

For Bethany Greenway, melanoma didn't appear in the form of an ominous dark spot doctors always warn about. Instead, the Texas mom noticed a subtle change when she was pregnant with her second child.

Use of SLNB for pure desmoplastic melanoma remains controversial. Accuracy of SLNB may be compromised in patients with prior wide local excision.

I don’t often use single agent, though. JANG: Desmoplastic melanoma is one of the subtypes that has a very high response rate to single-agent PD-1 antibody. In terms of subtypes of melanoma, for ...

ESPN commentator Holly Rowe was diagnosed with desmoplastic melanoma in 2015. The cancer metastasized to her lungs. Today, she's cancer-free and sharing her best tips for sun protection.

Other variants such as amelanotic melanoma (a melanoma that produces no pigment and presents as a red patch or bump), desmoplastic melanoma (presents as a white scar-like bump), and nevoid ...

Melanoma subtypes included were superficial spreading, nodular, acral, desmoplastic (pure ie, desmoplastic melanoma accounting for ≥90% of the invasive melanoma), lentigo maligna melanoma, and other ...

But it's the most common type of melanoma in people with brown or black skin. It's also most often diagnosed in middle aged and older adults. Desmoplastic melanoma can develop anywhere on your body ...

USA: A recent study has suggested that many patients with desmoplastic melanoma could avoid the risk of toxicity from combination therapies and achieve cancer control with immunotherapy (pembrolizumab ...

Credit: Getty Images. In a phase 2 trial, pembrolizumab produced an overall response rate of 89% in patients with unresectable desmoplastic melanoma. Pembrolizumab monotherapy may be the first ...

Desmoplastic melanoma is a subset of melanoma skin cancer that is caused by high levels of ultraviolet (UV) radiation damage and, therefore, a high number of tumor mutations that all contribute to ...

Opens in a new tab or window ORLANDO -- Exceedingly high response rates were seen with pembrolizumab (Keytruda) in patients with unresectable metastatic desmoplastic melanoma, according to results ...